MedPath
NMPA Approval

Doxazosin Mesylate Extended Release Tablets

国药准字H20253807

April 1, 2025

Drug Information

甲磺酸多沙唑嗪缓释片

片剂

4mg(按C₂₃H₂₅N₅O₅计)

化学药品

April 1, 2025

Company Information

Applicant Company

成都市新都卫星城工业开发区南二路

Manufacturing Company

四川省成都市新都卫星城工业开发区南二路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸多沙唑嗪缓释片 - NMPA 批准文号 | MedPath